MANUFACTURERS LIFE INSURANCE COMPANY, THE - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 487 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2014. The put-call ratio across all filers is 0.91 and the average weighting 1.2%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$29,002,000
+48.8%
1,246,774
+1.8%
0.03%
+45.5%
Q1 2018$19,490,000
-23.5%
1,224,242
-0.2%
0.02%
-18.5%
Q4 2017$25,482,000
+76.8%
1,226,232
+21.9%
0.03%
+58.8%
Q3 2017$14,415,000
-21.6%
1,005,933
-5.0%
0.02%
-22.7%
Q2 2017$18,376,000
+65.2%
1,059,100
+5.0%
0.02%
+57.1%
Q1 2017$11,124,000
+3.3%
1,008,571
+35.9%
0.01%
-6.7%
Q4 2016$10,773,000
-41.3%
741,896
-0.7%
0.02%
-44.4%
Q3 2016$18,342,000
+18.0%
747,110
-3.2%
0.03%
+12.5%
Q2 2016$15,546,000
-33.0%
771,878
-10.0%
0.02%
+20.0%
Q1 2016$23,213,000
-87.3%
857,497
-52.5%
0.02%
-88.5%
Q4 2015$183,452,000
-45.6%
1,804,747
-4.5%
0.17%
-51.1%
Q3 2015$337,055,000
+57.0%
1,889,536
+95.5%
0.36%
+39.1%
Q2 2015$214,725,000
+12.7%
966,577
+0.8%
0.26%
+5.8%
Q1 2015$190,463,000
+258.4%
958,932
+158.2%
0.24%
+214.3%
Q4 2014$53,148,000
-56.4%
371,379
-57.3%
0.08%
-57.2%
Q3 2014$121,959,000
+24.6%
870,076
+12.1%
0.18%
+21.6%
Q2 2014$97,912,000
-46.9%
776,338
-40.1%
0.15%
-49.5%
Q1 2014$184,238,000
+97.8%
1,295,711
+69.7%
0.29%
+102.1%
Q4 2013$93,128,000
+17.7%
763,435
+2.6%
0.14%
+9.8%
Q3 2013$79,128,000
+39.8%
744,302
+17.2%
0.13%
+23.4%
Q2 2013$56,613,000635,0340.11%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q2 2014
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,106,379$55,398,00031.67%
Claren Road Asset Management, LLC 80,000$2,820,00024.27%
Okumus Fund Management Ltd. 3,722,464$97,901,00015.82%
Wingspan Investment Management, LP 852,900$22,431,00012.66%
FARLEY CAPITAL L.P. 307,458$8,086,00011.46%
Chou Associates Management 976,843$25,725,0008.35%
Wingspan Investment Management, LP 550,700$14,483,0008.17%
HAP Trading, LLC 4,043,900$109,610,0008.00%
LeVasseur Capital Partners LLC 128,269$3,373,0006.97%
Pershing Square Capital Management 21,591,122$567,847,0006.41%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders